HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 649-660 of 1,811
Other study type icon
Enrolling By InvitationNCT05368493

Air Pollution and Development in the Boricua Youth Study

Official study title

Prenatal Air Pollution and Neurodevelopment: a Longitudinal Neuroimaging Study of Mechanisms and Early Risk for ADHD in Puerto Rican Children

This study is by invitation only.

Multiple locations, including New York
ADHDInterventional studyAges 6 months–11 years
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
CompletedNCT00500149

Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) for ADHD

Official study title

A Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Shire
Device study icon
CompletedNCT03066505

Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for ADHD

Official study title

A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With Attention Deficit Hyperactivity Disorder.

This study has finished and is no longer accepting participants.

In Los Angeles
ADHDDevice studyAges 18–25
Countries
United States
Sponsor
Wave Neuroscience
Drug study icon
CompletedNCT01364662

SPN-810 for ADHD

What is this study about?

This study evaluated the safety and effectiveness of SPN-810 for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT06359899

Safety study of AK0901 in ADHD

What is this study about?

This study evaluated the safety and effectiveness of AK0901 capsule for people with ADHD.

This study has finished and is no longer accepting participants.

In Beijing
ADHDMedication studyAges 6–12
Countries
China
Sponsor
Shanghai Ark Biopharmaceutical Co., Ltd.
Behavioral study icon
CompletedNCT05417607

A+ Treatment/Feasibility of Adapted ESDM-informed Caregiver Coaching Delivered Remotely for Children With ASD (Autism Spectrum Disorder) and ADHD (Attention Deficit Hyperactivity Disorder)

Official study title

Sub-study: Feasibility Trial of Adapted ESDM-informed Caregiver Coaching Delivered Remotely for Children With ASD and ADHD

This study has finished and is no longer accepting participants.

In Durham
ADHDBehavioural studyAges 36–131 months
Countries
United States
Sponsor
Duke University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.